Hot Stocks: Brokerage view on Lupin and Gujarat Gas; Marico gets an upgrade

Investec raised Marico's rating from hold to buy, while Jefferies upheld a buy rating for Godrej Consumer. JPMorgan continued to rate Gujarat Gas as underweight and maintained a neutral stance on Lupin.

Brokerage upgraded to a buy from hold, maintained a buy rating on , maintained an underweight rating on , and a neutral stance on .

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:


Investec on Marico: Buy| Target Rs 616


Investec upgraded to a buy from hold earlier and raised the target price to Rs 616 from Rs 572 earlier.

“The operating performance in Q4 was largely in line with estimates. Diversification in the India portfolio, return of pricing and recovering international performance provides us confidence,” said the note.

The near-term margins are unlikely to expand. The research firm believes that the company has sufficient triggers for longer-term margin improvement.

The volume-led revenue growth is likely to recover and that will boost multiples.

Jefferies on Godrej Consumer: Buy| Target Rs 1520


Jefferies maintained a buy rating on Godrej Consumer with a target price of Rs 1520. The Q4 earnings were above estimates with 18% LFL Ebitda growth.

Key positives include industry-leading volume growth, strong traction in Indonesia and good EBITDA delivery.

Weak HI was the key dampener, given extended winter, albeit further initiatives (LV launch) here should help.

JPMorgan on Gujarat Gas: Underweight| Target Rs 396


JPMorgan maintained an underweight rating on Gujarat Gas but raised the target price to Rs 396 from Rs 360 earlier.

The net profit was ahead of estimates on lower raw material costs, and one-off gains. The EBITDA per unit for the quarter increased significantly to Rs.6.7/scm.

It leaves room for upgrades if the company can drive volumes up and maintain Q4 margin run rates.

JPMorgan on Lupin: Neutral| Target Rs 1550


JPMorgan maintained a neutral rating on Lupin with a target price of Rs 1550.

The Q4 was broadly in line with estimates and margins were ahead of expectations. The key positives are margin improvement, continued strength in EMEA, and reduction in net debt.

However, lower growth in the India business is a key negative.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?